BSG and bladder transitional cell carcinoma: Similarly, Li et al. [21] demonstrated higher CD147 mRNA levels in bladder transitional cell carcinoma (59.7%) than in normal bladder tissue (0%), but found no difference with clinical stage (r=0.048, P=0.698) or histological differentiation (r=0.222, P=0.071).